Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer

Conclusion
These results suggest a potential opportunity exists to maximize oral chemotherapy treatment outcomes with the addition of a formalized monitoring program directed by an oncology pharmacist.

Source: Journal of Oncology Pharmacy Practice - October 25, 2016 Category: Cancer & Oncology Authors: Patel, J. M., Holle, L. M., Clement, J. M., Bunz, T., Niemann, C., Chamberlin, K. W. Tags: Original Articles Source Type: research